LIPOCINE INC. Research and Development Expense
LIPOCINE INC. (LPCN) reported Research and Development Expense of $2.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- LIPOCINE INC. research and development expense for the quarter ending 2026-06-30 was $2.04M, a 4.46% decline year-over-year.
- LIPOCINE INC. research and development expense for the quarter ending 2026-03-31 was $2.76M, a 160.41% increase year-over-year.
- LIPOCINE INC. research and development expense for the quarter ending 2025-12-31 was $2.68M, a 149.59% increase year-over-year.
- LIPOCINE INC. research and development expense for the quarter ending 2025-09-30 was $2.71M, a 70.81% increase year-over-year.
- LIPOCINE INC. research and development expense for fiscal 2025 was $8.58M, a 16.76% increase from fiscal 2024.
- LIPOCINE INC. research and development expense for fiscal 2024 was $7.35M, a 27.75% decline from fiscal 2023.
- LIPOCINE INC. research and development expense for fiscal 2023 was $10.18M, a 18.91% increase from fiscal 2022.
- LIPOCINE INC. research and development expense for fiscal 2022 was $8.56M, a 11.63% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.04M 10-Q · filed 2026-08-04 | $4.81M 10-Q · filed 2026-08-04 | $7.48M derived: sum of 3 quarters · filed 2026-08-04 | $10.19M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $2.76M 10-Q · filed 2026-05-07 | $5.44M derived: sum of 2 quarters · filed 2026-05-07 | $8.15M derived: sum of 3 quarters · filed 2026-05-07 | $10.29M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $5.39M derived: sum of 2 quarters · filed 2026-03-10 | $7.52M derived: sum of 3 quarters · filed 2026-08-04 | $8.58M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $2.71M 10-Q · filed 2025-11-06 | $4.84M derived: sum of 2 quarters · filed 2026-08-04 | $5.91M 10-Q · filed 2025-11-06 | $6.98M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $2.14M 10-Q · filed 2026-08-04 | $3.20M 10-Q · filed 2026-08-04 | $4.27M derived: sum of 3 quarters · filed 2026-08-04 | $5.86M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $1.06M 10-Q · filed 2026-05-07 | $2.13M derived: sum of 2 quarters · filed 2026-05-07 | $3.72M derived: sum of 3 quarters · filed 2026-05-07 | $5.59M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.66M derived: sum of 2 quarters · filed 2026-03-10 | $4.53M derived: sum of 3 quarters · filed 2026-03-10 | $7.35M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $1.59M 10-Q · filed 2025-11-06 | $3.46M derived: sum of 2 quarters · filed 2025-11-06 | $6.28M 10-Q · filed 2025-11-06 | $7.95M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $1.87M 10-Q · filed 2025-08-05 | $4.69M 10-Q · filed 2025-08-05 | $6.37M derived: sum of 3 quarters · filed 2025-08-05 | $9.25M derived: sum of 4 quarters · filed 2025-08-05 | |||
| 2024-03-31 | $2.82M 10-Q · filed 2025-05-08 | $4.49M derived: sum of 2 quarters · filed 2025-05-08 | $7.37M derived: sum of 3 quarters · filed 2025-05-08 | $9.89M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $4.55M derived: sum of 2 quarters · filed 2025-03-13 | $7.07M derived: sum of 3 quarters · filed 2025-03-13 | $10.18M 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $2.88M 10-Q · filed 2024-11-07 | $5.39M derived: sum of 2 quarters · filed 2024-11-07 | $8.50M 10-Q · filed 2024-11-07 | $10.17M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $2.52M 10-Q · filed 2024-08-08 | $5.62M 10-Q · filed 2024-08-08 | $7.29M derived: sum of 3 quarters · filed 2024-08-08 | $9.39M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $3.11M 10-Q · filed 2024-05-09 | $4.78M derived: sum of 2 quarters · filed 2024-05-09 | $6.88M derived: sum of 3 quarters · filed 2024-05-09 | $9.78M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $3.77M derived: sum of 2 quarters · filed 2024-03-07 | $6.67M derived: sum of 3 quarters · filed 2024-03-07 | $8.56M 10-K · filed 2024-03-07 | |||
| 2022-09-30 | $2.10M 10-Q · filed 2023-11-08 | $5.00M derived: sum of 2 quarters · filed 2023-11-08 | $6.89M 10-Q · filed 2023-11-08 | $9.14M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $2.90M 10-Q · filed 2023-08-10 | $4.79M 10-Q · filed 2023-08-10 | $7.04M derived: sum of 3 quarters · filed 2023-08-10 | $9.41M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $1.89M 10-Q · filed 2023-05-11 | $4.14M derived: sum of 2 quarters · filed 2023-05-11 | $6.51M derived: sum of 3 quarters · filed 2023-05-11 | $7.97M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $4.62M derived: sum of 2 quarters · filed 2023-03-10 | $6.09M derived: sum of 3 quarters · filed 2023-03-10 | $7.67M 10-K · filed 2023-03-10 | |||
| 2021-09-30 | $2.37M 10-Q · filed 2022-11-09 | $3.83M derived: sum of 2 quarters · filed 2022-11-09 | $5.41M 10-Q · filed 2022-11-09 | $7.89M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $1.46M 10-Q · filed 2022-08-08 | $3.05M 10-Q · filed 2022-08-08 | $5.53M derived: sum of 3 quarters · filed 2022-08-08 | $8.01M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-09 | $4.06M derived: sum of 2 quarters · filed 2022-05-09 | $6.55M derived: sum of 3 quarters · filed 2022-05-09 | $8.82M derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $4.97M derived: sum of 2 quarters · filed 2022-03-09 | $7.24M derived: sum of 3 quarters · filed 2022-03-09 | $9.75M 10-K · filed 2022-03-09 | |||
| 2020-09-30 | $2.49M 10-Q · filed 2021-11-10 | $4.76M derived: sum of 2 quarters · filed 2021-11-10 | $7.27M 10-Q · filed 2021-11-10 | $9.11M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $2.27M 10-Q · filed 2021-08-05 | $4.78M 10-Q · filed 2021-08-05 | $6.62M derived: sum of 3 quarters · filed 2021-08-05 | $8.33M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $2.51M 10-Q · filed 2021-05-06 | $4.35M derived: sum of 2 quarters · filed 2021-05-06 | $6.07M derived: sum of 3 quarters · filed 2021-05-06 | $8.03M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.55M derived: sum of 2 quarters · filed 2021-03-11 | $5.52M derived: sum of 3 quarters · filed 2021-03-11 | $7.47M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $1.71M 10-Q · filed 2020-11-10 | $3.68M derived: sum of 2 quarters · filed 2020-11-10 | $5.63M 10-Q · filed 2020-11-10 | $5.63M 10-Q · filed 2019-11-12 | $7.81M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $1.96M 10-Q · filed 2020-08-06 | $3.91M 10-Q · filed 2020-08-06 | $3.91M 10-Q · filed 2019-08-07 | $6.10M derived: sum of 3 quarters · filed 2020-08-06 | $7.52M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $1.95M 10-Q · filed 2020-05-07 | $1.95M 10-Q · filed 2019-05-08 | $4.13M derived: sum of 2 quarters · filed 2020-05-07 | $5.55M derived: sum of 3 quarters · filed 2020-05-07 | $7.04M derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.60M derived: sum of 2 quarters · filed 2020-03-13 | $5.09M derived: sum of 3 quarters · filed 2020-03-13 | $6.46M 10-K · filed 2020-03-13 | |||
| 2018-09-30 | $1.42M 10-Q · filed 2019-11-12 | $2.91M derived: sum of 2 quarters · filed 2019-11-12 | $4.28M 10-Q · filed 2019-11-12 | $6.05M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $1.48M 10-Q · filed 2019-08-07 | $2.86M 10-Q · filed 2019-08-07 | $4.63M derived: sum of 3 quarters · filed 2019-08-07 | $6.67M derived: sum of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | $1.38M 10-Q · filed 2019-05-08 | $3.14M derived: sum of 2 quarters · filed 2019-05-08 | $5.19M derived: sum of 3 quarters · filed 2019-05-08 | $9.30M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $3.81M derived: sum of 2 quarters · filed 2019-03-06 | $7.92M derived: sum of 3 quarters · filed 2019-03-06 | $11.00M 10-K · filed 2019-03-06 | |||
| 2017-09-30 | $2.05M 10-Q · filed 2018-11-07 | $6.15M derived: sum of 2 quarters · filed 2018-11-07 | $9.24M 10-Q · filed 2018-11-07 | $10.57M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-06-30 | $4.11M 10-Q · filed 2018-08-07 | $7.19M 10-Q · filed 2018-08-07 | $8.52M derived: sum of 3 quarters · filed 2019-03-06 | $10.03M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-03-31 | $3.08M 10-Q · filed 2018-05-07 | $4.41M derived: sum of 2 quarters · filed 2019-03-06 | $5.92M derived: sum of 3 quarters · filed 2019-03-06 | $8.49M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2016-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $2.83M derived: sum of 2 quarters · filed 2019-03-06 | $5.40M derived: sum of 3 quarters · filed 2019-03-06 | $8.08M 10-K · filed 2019-03-06 | |||
| 2016-09-30 | $1.51M 10-Q · filed 2017-11-08 | $4.07M derived: sum of 2 quarters · filed 2017-11-08 | $6.75M 10-Q · filed 2017-11-08 | $9.51M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-06-30 | $2.57M 10-Q · filed 2017-08-07 | $5.24M 10-Q · filed 2017-08-07 | $8.01M derived: sum of 3 quarters · filed 2018-03-12 | $12.74M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2016-03-31 | $2.67M 10-Q · filed 2017-05-08 | $5.44M derived: sum of 2 quarters · filed 2018-03-12 | $10.17M derived: sum of 3 quarters · filed 2018-03-12 | $13.33M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $7.50M derived: sum of 2 quarters · filed 2018-03-12 | $10.66M derived: sum of 3 quarters · filed 2018-03-12 | $12.58M 10-K · filed 2018-03-12 | |||
| 2015-09-30 | $4.73M 10-Q · filed 2016-11-08 | $7.90M derived: sum of 2 quarters · filed 2016-11-08 | $9.81M 10-Q · filed 2016-11-08 | $12.70M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2015-06-30 | $3.16M 10-Q · filed 2016-08-09 | $5.08M 10-Q · filed 2016-08-09 | $7.97M derived: sum of 3 quarters · filed 2017-03-06 | $11.22M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2015-03-31 | $1.92M 10-Q · filed 2016-05-09 | $4.81M derived: sum of 2 quarters · filed 2017-03-06 | $8.06M derived: sum of 3 quarters · filed 2017-03-06 | $14.03M derived: sum of 4 quarters · filed 2017-03-06 | |||
| 2014-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $6.14M derived: sum of 2 quarters · filed 2017-03-06 | $12.11M derived: sum of 3 quarters · filed 2017-03-06 | $15.48M 10-K · filed 2017-03-06 | |||
| 2014-09-30 | $3.25M 10-Q · filed 2015-11-12 | $9.22M derived: sum of 2 quarters · filed 2015-11-12 | $12.59M 10-Q · filed 2015-11-12 | $15.05M derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-06-30 | $5.97M 10-Q · filed 2015-08-11 | $9.34M 10-Q · filed 2015-08-11 | $11.81M derived: sum of 3 quarters · filed 2015-08-11 | $13.38M derived: sum of 4 quarters · filed 2015-08-11 | |||
| 2014-03-31 | $3.37M 10-Q · filed 2015-05-07 | $5.83M derived: sum of 2 quarters · filed 2015-05-07 | $7.40M derived: sum of 3 quarters · filed 2015-05-07 | $7.85M derived: sum of 4 quarters · filed 2015-05-07 | |||
| 2013-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $4.03M derived: sum of 2 quarters · filed 2015-03-11 | $4.48M derived: sum of 3 quarters · filed 2015-03-11 | $5.12M 10-K · filed 2015-03-11 | |||
| 2013-09-30 | $1.57M 10-Q · filed 2014-11-10 | $2.01M derived: sum of 2 quarters · filed 2014-11-10 | $2.66M 10-Q · filed 2014-11-10 | $3.24M derived: sum of 4 quarters · filed 2014-11-10 | |||
| 2013-06-30 | $443.86K 10-Q · filed 2014-08-13 | $1.09M 10-Q · filed 2014-08-13 | $1.67M derived: sum of 3 quarters · filed 2014-08-13 | $2.22M derived: sum of 4 quarters · filed 2014-08-13 | |||
| 2013-03-31 | $645.11K 10-Q · filed 2014-05-13 | $1.23M derived: sum of 2 quarters · filed 2014-05-13 | $1.78M derived: sum of 3 quarters · filed 2014-05-13 | ||||
| 2012-12-31 | $584.77K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.13M derived: sum of 2 quarters · filed 2014-03-31 | $2.28M 10-K · filed 2014-03-31 | ||||
| 2012-09-30 | $547.82K 10-Q · filed 2013-11-13 | $1.70M 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |